Author Login

• Review Article
• Open Access
• Mishael N. Welder

A surprising percentage of seminal articles appear to be unreproducible by independent labs, per a number of recent investigations. An important part of this is played by nontherapeutic antibodies used for environmental, dietary, diagnostic, research, and other applications.

• Case Report
• Open Access
• Nioola Cotagno

Remdesivir and SARS-CoV-2-neutralizing monoclonal antibodies were among the several treatment medications used to treat a patient with activated PI3K-kinase delta syndrome (APDS) and a persistent, asymptomatic SARS-CoV-2 infection.

• Review Article
• Open Access
• Hank Seoan Lee

One of the main causes of end-stage kidney disease worldwide, particularly in affluent nations, is diabetic nephropathy (DN). Microalbuminuria is a hallmark of the traditional pathogenic progression of DN, which leads to nephrotic-range proteinuria and renal function loss. In individuals with DN, the level of albuminuria is thought to be a separate risk factor for all-cause death.

• Editorial
• Open Access
• Kelvin H. Senry

The basic characteristics of sdAbs were covered in one original study. In order to comprehend the perhaps different mechanisms of sdAbs’ recognition of antigens, Gordon et al. analyzed the structures of 345 sdAb:antigen complexes with 892 conventional antibody:antigen complexes in the largest study of this kind to date. T.

• Research Article
• Open Access
• Shivam Bhujani

For eligible patients with end-stage kidney disease (ESKD), kidney transplantation is the recommended form of kidney replacement therapy since it has been shown to lower death rates, enhance quality of life, and be more affordable than dialysis.